TY - JOUR
T1 - Cognition in first-episode psychosis
T2 - From phenomenology to intervention
AU - Breitborde, Nicholas J.K.
AU - Meier, Madeline
N1 - Publisher Copyright:
© 2016 Bentham Science Publishers.
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Available research has clearly demonstrated that individuals with longstanding psychotic disorders have deficits in cognitive functioning that (i) have deleterious effects on their everyday functioning and (ii) can be partially ameliorated via available treatment options. Despite the fact that the cognitive deficits that accompany psychotic disorders are largely present by the time of the first-episode of psychosis, the nature of these associations in first-episode psychosis is less clear. Data are mixed with regard to a possible association between neurocognition and real-world functioning among individuals with first-episode psychosis, possibly due in part to methodological limitations of available studies. Although cognitive remediation has shown promise in ameliorating cognitive and functional deficits among individuals with longstanding psychotic disorder, these associations are not as robust for individuals with first-episode psychosis. With regard to pharmacological treatment, available data suggest that antipsychotic medications do not produce meaningful gains in cognitive functioning. Data in support of other pro-cognitive pharmacological agents are also limited. Ultimately, further research using methodologically sound approaches is needed to clarify the role of cognitive deficits in the disability that accompanies first-episode psychosis and to identify the most effective interventions with which to ameliorate these cognitive deficits.
AB - Available research has clearly demonstrated that individuals with longstanding psychotic disorders have deficits in cognitive functioning that (i) have deleterious effects on their everyday functioning and (ii) can be partially ameliorated via available treatment options. Despite the fact that the cognitive deficits that accompany psychotic disorders are largely present by the time of the first-episode of psychosis, the nature of these associations in first-episode psychosis is less clear. Data are mixed with regard to a possible association between neurocognition and real-world functioning among individuals with first-episode psychosis, possibly due in part to methodological limitations of available studies. Although cognitive remediation has shown promise in ameliorating cognitive and functional deficits among individuals with longstanding psychotic disorder, these associations are not as robust for individuals with first-episode psychosis. With regard to pharmacological treatment, available data suggest that antipsychotic medications do not produce meaningful gains in cognitive functioning. Data in support of other pro-cognitive pharmacological agents are also limited. Ultimately, further research using methodologically sound approaches is needed to clarify the role of cognitive deficits in the disability that accompanies first-episode psychosis and to identify the most effective interventions with which to ameliorate these cognitive deficits.
KW - Cognition
KW - Cognitive enhancement
KW - Cognitive remediation
KW - First-episode psychosis
KW - Pharmacology
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85012065220&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85012065220&partnerID=8YFLogxK
U2 - 10.2174/1573400512666160927145737
DO - 10.2174/1573400512666160927145737
M3 - Review article
AN - SCOPUS:85012065220
SN - 2666-0822
VL - 12
SP - 306
EP - 318
JO - Current Psychiatry Research and Reviews
JF - Current Psychiatry Research and Reviews
IS - 4
ER -